187 related articles for article (PubMed ID: 35764285)
1. The Role of Omalizumab in NSAID-Exacerbated Respiratory Disease: A Narrative Review.
Taniguchi M; Heffler E; Olze H; White A; Côrte-Real J; Olsson P; Lazarewicz S
J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2570-2578. PubMed ID: 35764285
[TBL] [Abstract][Full Text] [Related]
2. Omalizumab-Induced Aspirin Tolerance in Nonsteroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease Patients Is Independent of Atopic Sensitization.
Quint T; Dahm V; Ramazanova D; Arnoldner MA; Kurz H; Janik S; Brunner PM; Knerer-Schally B; Weninger W; Griss J; Ristl R; Schneider S; Bangert C
J Allergy Clin Immunol Pract; 2022 Feb; 10(2):506-516.e6. PubMed ID: 34678497
[TBL] [Abstract][Full Text] [Related]
3. The role of oxylipins in NSAID-exacerbated respiratory disease (N-ERD).
Cousins K; Chen CC; Sehanobish E; Jerschow E
Adv Pharmacol; 2023; 97():423-444. PubMed ID: 37236766
[TBL] [Abstract][Full Text] [Related]
4. Sex, Ethnicity, Body Mass Index, and Environmental Exposures Associated With NSAID-Exacerbated Respiratory Disease Symptom Sequence.
Dages KN; Sofola-James O; Sehanobish E; Regula P; Chen CC; Chiarella SE; Divekar RD; Cohen HW; Jerschow E
J Allergy Clin Immunol Pract; 2023 Dec; 11(12):3662-3669.e2. PubMed ID: 37541619
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal Anti-inflammatory Drug (NSAID) Tolerance After Biological Therapy in Patients With NSAID-Exacerbated Respiratory Disease: A Randomized Comparative Trial.
Sánchez J; García E; Lopez JF; Calle A; Buendia JA
J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2172-2179. PubMed ID: 37146885
[TBL] [Abstract][Full Text] [Related]
6. Biologics Reduce Symptoms of Alcohol Intolerance Better than Aspirin Desensitization in Patients with N-ERD and Nasal Polyps.
Foerster-Ruhrmann U; Jurkov M; Szczepek AJ; Bergmann KC; Fluhr JW; Olze H
Biomedicines; 2024 May; 12(5):. PubMed ID: 38790987
[TBL] [Abstract][Full Text] [Related]
7. Omalizumab in patients with NSAIDs-exacerbated respiratory disease.
Forster-Ruhrmann U; Stergioudi D; Pierchalla G; Fluhr JW; Bergmann KC; Olze H
Rhinology; 2020 Jun; 58(3):226-232. PubMed ID: 32077449
[TBL] [Abstract][Full Text] [Related]
8. Bronchial epithelial cell transcriptome shows endotype heterogeneity of asthma in patients with NSAID-exacerbated respiratory disease.
Jakiela B; Soja J; Sladek K; Przybyszowski M; Plutecka H; Gielicz A; Licholai S; Aab A; Rebane A; Bochenek G
J Allergy Clin Immunol; 2023 Apr; 151(4):953-965. PubMed ID: 36395984
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
Mullol J; Laidlaw TM; Bachert C; Mannent LP; Canonica GW; Han JK; Maspero JF; Picado C; Daizadeh N; Ortiz B; Li Y; Ruddy M; Laws E; Amin N
Allergy; 2022 Apr; 77(4):1231-1244. PubMed ID: 34459002
[TBL] [Abstract][Full Text] [Related]
10. Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD.
Tepetam FM; Özden Ş; Kılıç FK; Örçen C; Yakut T
World Allergy Organ J; 2023 Sep; 16(9):100817. PubMed ID: 37771938
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
Van Broeck D; Steelant B; Scadding G; Hellings PW
Front Allergy; 2023; 4():1080951. PubMed ID: 37123562
[TBL] [Abstract][Full Text] [Related]
12. Inheritance of NSAID-Exacerbated Respiratory Disease.
Suikkila A; Lyly A; Hafrén L; Saarinen R; Klockars T
Otolaryngol Head Neck Surg; 2023 Mar; 168(3):540-543. PubMed ID: 35639475
[TBL] [Abstract][Full Text] [Related]
13. Omalizumab in patient with aspirin exacerbated respiratory disease and chronic idiopathic urticaria.
Porcaro F; Di Marco A; Cutrera R
Pediatr Pulmonol; 2017 May; 52(5):E26-E28. PubMed ID: 27685608
[TBL] [Abstract][Full Text] [Related]
14. Effect of omalizumab on outcomes in patients with aspirin-exacerbated respiratory disease.
Jean T; Eng V; Sheikh J; Kaplan MS; Goldberg B; Jau Yang S; Samant S
Allergy Asthma Proc; 2019 Sep; 40(5):316-320. PubMed ID: 31514790
[No Abstract] [Full Text] [Related]
15. Can nasal acetylsalicylic acid challenge predict the severity of non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated respiratory disease (N-ERD)?
.
Förster-Ruhrmann U; Tietz AK; Kim J; Liebers U; Szczepek AJ; Olze H
Allergol Select; 2020; 4():135-143. PubMed ID: 33393939
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper.
Kowalski ML; Agache I; Bavbek S; Bakirtas A; Blanca M; Bochenek G; Bonini M; Heffler E; Klimek L; Laidlaw TM; Mullol J; Niżankowska-Mogilnicka E; Park HS; Sanak M; Sanchez-Borges M; Sanchez-Garcia S; Scadding G; Taniguchi M; Torres MJ; White AA; Wardzyńska A
Allergy; 2019 Jan; 74(1):28-39. PubMed ID: 30216468
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of lower airway inflammation in patients with NSAID-exacerbated respiratory disease.
Jakiela B; Soja J; Sladek K; Przybyszowski M; Plutecka H; Gielicz A; Rebane A; Bochenek G
J Allergy Clin Immunol; 2021 Apr; 147(4):1269-1280. PubMed ID: 32810516
[TBL] [Abstract][Full Text] [Related]
18. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
Holgate ST; Djukanović R; Casale T; Bousquet J
Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory macrophage memory in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease.
Haimerl P; Bernhardt U; Schindela S; Henkel FDR; Lechner A; Zissler UM; Pastor X; Thomas D; Cecil A; Ge Y; Haid M; Prehn C; Tokarz J; Heinig M; Adamski J; Schmidt-Weber CB; Chaker AM; Esser-von Bieren J
J Allergy Clin Immunol; 2021 Feb; 147(2):587-599. PubMed ID: 32540397
[TBL] [Abstract][Full Text] [Related]
20. NSAID-ERD Syndrome: the New Hope from Prevention, Early Diagnosis, and New Therapeutic Targets.
Laidlaw TM; Levy JM
Curr Allergy Asthma Rep; 2020 Mar; 20(4):10. PubMed ID: 32172365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
